Welcome to Ligand Pharmaceuticals

Ligand is a high-growth company with economic rights to some of the world's most important medicines.

Portfolio
Technologies
Licensing Opportunities

Latest News

Ligand Pharmaceuticals Appoints Jason Haas to its Board of Directors

Read More

Ligand Reports First Quarter 2022 Financial Results

Read More

Ligand to Report First Quarter Financial Results on May 4

Read More

Recent Events

Stock Snapshot

LGND
Nasdaq
Volume
Market Cap
Day Range
52-Week Range